Suchergebnisse - "Richardson, Peter"

PubPharm (15)

1

Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients

enthalten in: ResearchSquare.com | 2022

von Stebbing, J. | Krishnan, V. | de Bono, S. | +14

2

Baricitinib as the treatment of choice for hospitalised individuals with COVID-19

enthalten in: EClinicalMedicine | 2022

von Richardson, P. | Stebbing, J.

3

The AI-Assisted Identification and Clinical Efficacy of Baricitinib in the Treatment of COVID-19

enthalten in: Vaccines | 2022

von Richardson, P. | Robinson, B. | Smith, D. | +1

4

Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19 : A Randomized Clinical Trial

enthalten in: JAMA | 2021

von Writing Committee for the REMAP-CAP Investigators | Estcourt, L. | Turgeon, A. | +190

5

The Emergence of Baricitinib : A Story of Tortoises Versus Hares

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2021

von Lenz, H. | Richardson, P. | Stebbing, J.

6

JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality

enthalten in: Science advances | 2021

von Stebbing, J. | Sánchez Nievas, G. | Falcone, M. | +47

7

Expert-Augmented Computational Drug Repurposing Identified Baricitinib as a Treatment for COVID-19

enthalten in: Frontiers in pharmacology | 2021

von Smith, D. | Oechsle, O. | Rawling, M. | +3

8

Baricitinib for COVID-19 : a suitable treatment? - Authors' reply

enthalten in: The Lancet. Infectious diseases | 2020

von Richardson, P. | Corbellino, M. | Stebbing, J.

CommentOn: Lancet Infect Dis. 2020 Apr;20(4):400-402. - PMID 32113509

9

Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients

enthalten in: EMBO molecular medicine | 2020

von Stebbing, J. | Krishnan, V. | de Bono, S. | +20

CommentIn: EMBO Mol Med. 2020 Aug 7;12(8):e12817. - PMID 32569446

10

CNS penetration of potential anti-COVID-19 drugs

enthalten in: Journal of neurology | 2020

von Richardson, P. | Ottaviani, S. | Prelle, A. | +3